These breakthroughs underscore the therapeutic potential of precision modulation of the TR2/TR4 complex’s epigenetic activity, offering a causal intervention to ameliorate the pathological progression of hemoglobinopathies. Here, NR2C2 is linked to hemoglobinopathy.